China: Retail price management case highlights clashing approaches to antitrust law
A ruling by the Shanghai Intermediate People’s Court against Rainbow Medical, which alleged Johnson & Johnson hampered competition with a contract between the two parties, has been appealed to the Shanghai Higher People’s Court. According to a report, the situation is part of a larger trend of conflicting governmental approaches to retail price maintenance cases under the PRC Anti-monopoly Law. Quoted is antitrust lawyer Zhaofeng Zhou, noting that in this particular case the court used an approach “similar to the US rule of reason,” while the National Development and Reform Commission, China’s antitrust authority, used the per se illegal approach “commonly found in the EU.”
Featured News
Mexico Antitrust Authority Fines Oxygen Suppliers Over Exclusive Contracts
Mar 19, 2026 by
CPI
EU Cloud Group Pushes for Halt to Broadcom VMware Changes
Mar 19, 2026 by
CPI
Sen. Blackburn Releases Discussion Draft of Bill to Set Federal ‘Framework’ for AI Policy
Mar 19, 2026 by
CPI
Nexstar and Tegna’s Local TV Megamerger Challenged by Eight States
Mar 19, 2026 by
CPI
DOJ Antitrust Chief Says Paramount-WBD Deal Won’t Get Special Treatment
Mar 19, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Data-Driven Competition
Mar 19, 2026 by
CPI
Data-Driven Competition: Implications For Enforcement and Merger Control
Mar 19, 2026 by
Alexandre de Corniere & Greg Taylor
From Tipping to Trustees: Why Data-Driven Markets Require Institutional Design, Not Optimization
Mar 19, 2026 by
Jens Prüfer & Paul de Bijl
Data Barriers to Entry: What We’ve Learned About Spotting Them and What We Still Don’t Know About Solutions
Mar 19, 2026 by
Bruno Carballa-Smichowski
When the Perfect Is the Enemy of the Good: Price Discrimination, Affordability, Precarity and Market Dynamism
Mar 19, 2026 by
Dan Ciuriak